tirzepatide cause death SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Explained: The Future of

[Abstract]2024 Sep;104(3):e14620

Start here: a simple, practical guide The Weight Loss Trio: Understanding Muscle Loss, Appetite, and Nausea on GLP-1s Understand why GLP-1 medications cause muscle loss, appetite suppression, and nausea, and how to manage GLP-1 Agonists and Sleep Disorders: How the Treatment Protocol Changed OSA is the most clinically well-studied sleep disorder in the GLP-1 space and the one GLP-1 and Fatty Liver Disease: What the Trial Data Keeps Showing Beyond Weight Loss GLP-1 agonists improve fatty liver through direct hepatic mechanisms, not just weight loss

Both outcomes are normal

Customer feedback is important for product and service quality, researchers are encouraged to leave a review

If your ALT or AST spike significantly after starting tirzepatide, that warrants immediate medical attention